Concomitant Drug


Indications and Reactions:

Role Indications Reactions
Secondary
Rectal Cancer 100.0%
Proctalgia 100.0%
Concomitant
Drug Use For Unknown Indication 58.6%
Product Used For Unknown Indication 16.8%
Asthma 5.2%
Acute Leukaemia 2.8%
Diffuse Large B-cell Lymphoma 2.1%
B-cell Lymphoma 1.7%
Non-hodgkin's Lymphoma 1.5%
Breast Cancer Metastatic 1.4%
Bronchopulmonary Aspergillosis 1.4%
Hypersensitivity 1.4%
Colorectal Cancer Metastatic 1.1%
Lung Neoplasm Malignant 0.9%
Premedication 0.8%
Breast Cancer 0.7%
Gastric Cancer 0.7%
Non-small Cell Lung Cancer 0.7%
Rheumatoid Arthritis 0.7%
Systemic Lupus Erythematosus 0.6%
Acute Myeloid Leukaemia 0.5%
Hypertension 0.5%
Rectal Haemorrhage 13.9%
Pyrexia 8.7%
Asthma 7.8%
Cataract 7.0%
Conjunctival Haemorrhage 7.0%
Febrile Neutropenia 5.2%
Skin Necrosis 5.2%
Coronary Artery Disease 4.3%
Pneumonitis 4.3%
Weight Increased 4.3%
Wheezing 4.3%
Adverse Drug Reaction 3.5%
Death 3.5%
Diplopia 3.5%
Respiratory Distress 3.5%
Sepsis 3.5%
Bronchopulmonary Aspergillosis 2.6%
Nasopharyngitis 2.6%
Pruritus 2.6%
Septic Shock 2.6%

Drug Data